Didier Plan

Didier Plan Email and Phone Number

Consultant Medical Affairs @
Didier Plan's Location
Greater Dijon Area, France
Didier Plan's Contact Details

Didier Plan work email

Didier Plan personal email

n/a
About Didier Plan

20+-year experience in developing, launching and promoting drugs and medical devices by setting up the relevant regulatory strategies

Didier Plan's Current Company Details
PCD, Plan for Clinical Development, France

Pcd, Plan For Clinical Development, France

Consultant Medical Affairs
Didier Plan Work Experience Details
  • Pcd, Plan For Clinical Development, France
    Consultant Medical Affairs
    Pcd, Plan For Clinical Development, France Sep 2008 - Present
    Early clinical development and/or regulatory filing in Europe for several products in cardiology, infectiology and immunology including a new drug-eluting stent (Biotronik, Zurich) and a vaccine candidate against AIDS (InnaVirVax, Paris)
  • Galderma, Sophia Antipolis, France
    Senior Project Manager
    Galderma, Sophia Antipolis, France Oct 2006 - Jun 2008
    Life-cycle management of amorolfine (Loceryl®- €90 million/year) in onychomycosis including regulatory filing (extension of indications, OTC switch and preparation of answers to the issues arisen by national agencies), due diligence, and the phase II-III clinical development of a new formulation of the product in Europe
  • Bard Electrophysiology, Lowell, Ma, Usa
    Head Of Clinical Affairs Europe
    Bard Electrophysiology, Lowell, Ma, Usa Aug 2004 - Jan 2006
    Life-cycle management and clinical development of 3 different mapping and ablation catheter systems (RF Mesh, Mesh Mapper, and Stinger® 8mm) in cardiac arrhythmia
  • Biotech & Medtech Companies
    Consultant
    Biotech & Medtech Companies Mar 2001 - Jun 2004
    Clinical plan designing and involvement in three first-round venture-capital fund raising discussions for 7 different emerging companies specializing in cancer, infectious diseases and dentistry
  • Mednova / Abbott, Galway, Ireland
    Head Of Medical Affairs
    Mednova / Abbott, Galway, Ireland Aug 1999 - Feb 2001
    Regulatory filing and clinical development in Europe of a new vascular protection system (EmboShield®) in patients undergoing angioplasty, which resulted in its marketing authorization approval (CE mark) and MedNova’s acquisition by Abbott
  • Cordis
    Manager Clinical Research Europe
    Cordis May 1997 - Apr 1999
    Regulatory filing, clinical development (29 trials resulting in 47 articles in peer-review journals, 240 hospitals, 25 countries, $10 million/year budget) and medical promotion of 11 different vascular stent systems and a brachytherapy system (Checkmate®)
  • Synthelabo, Paris, France
    Manager International Clinical Projects
    Synthelabo, Paris, France Oct 1990 - May 1997
    Alignment of the clinical development of leading products to regulatory requirements and marketing objectives: Mono-Tildiem®, Dogmatil®, Tiapridal® (also: Delpral® or Tiapridex®), Xatral SR® ($130, 110, 30 and 50 million/year, respectively) in coronary artery disease and hypertension, somatization, anxiety and benign prostatic hypertrophy, respectively.
  • Jouveinal, Paris, France
    Manager Clinical Affairs Allergy
    Jouveinal, Paris, France Aug 1989 - Aug 1990
    - Completion of a pivotal phase II-III study and 4 pharmacological studies on a new inhaled corticosteroid (JO1222) in asthma in Europe (10 countries) and Ontario - Regulatory filing
  • Pierre Fabre
    Manager Clinical Research Immunology
    Pierre Fabre Sep 1986 - Jun 1989
    - Clinical development in Europe of ribosomal extracts from Candida albicans (D651) and respiratory germs (Ribomunyl® or Immucytal® - $ 30 million/year) in the prevention of vulvovaginal mycoses and lung and ENT infections, respectively; - Regulatory filing and medical promotion of Ribomunyl® in Europe
  • Institut Mérieux, Lyon, France
    Project Leader
    Institut Mérieux, Lyon, France Jul 1980 - Sep 1986
    - Pharmaceutical preparation of leucocyte interferon purified to homogeneity including the setting-up of analytical and pharmacological controls- Creation and management of the “Association of European Producers of Interferon” aimed at establishing preclinical standards and identifying potential clinical indications- Creation and management of a specific legal entity aimed at developing and marketing blood cell-derived products jointly with the French Blood Centers

Didier Plan Skills

Clinical Research Immunology Clinical Trials Vaccines Medical Affairs Clinical Development Drug Development Medical Devices Cardiology Ctms Infectious Diseases Cancer Regulatory Affairs Pharmaceutical Industry Gcp Medicine Cro

Didier Plan Education Details

Frequently Asked Questions about Didier Plan

What company does Didier Plan work for?

Didier Plan works for Pcd, Plan For Clinical Development, France

What is Didier Plan's role at the current company?

Didier Plan's current role is Consultant Medical Affairs.

What is Didier Plan's email address?

Didier Plan's email address is di****@****plan.fr

What schools did Didier Plan attend?

Didier Plan attended Essec Business School, Université Claude Bernard Lyon 1, Université Claude Bernard Lyon 1.

What skills is Didier Plan known for?

Didier Plan has skills like Clinical Research, Immunology, Clinical Trials, Vaccines, Medical Affairs, Clinical Development, Drug Development, Medical Devices, Cardiology, Ctms, Infectious Diseases, Cancer.

Not the Didier Plan you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.